Publication | Open Access

Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway

Mtorc1 PathwayAutoimmune DiseaseConverts Ctl ExhaustionImmunologyTherapeutic VaccineAutoimmunityT Cell ImmunityCd4 T Cell ResponsesCellular Immune ResponseImmunotherapyMedicineCell BiologyChronic Infection